查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947027

2026年全球肺部藥物輸送裝置市場報告

Pulmonary Drug Delivery Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，肺部給藥裝置市場經歷了顯著成長，預計將從2025年的528億美元成長到2026年的564.9億美元，複合年成長率為7.0%。過去幾年的成長可歸因於呼吸系統疾病盛行率的上升、吸入療法使用量的增加、氣喘和慢性阻塞性肺病治療計畫的擴展、吸入器設計技術的改進以及人們對肺部給藥認知的提高。

預計未來幾年肺部給藥裝置市場將維持強勁成長，到2030年市場規模將達到719億美元，複合年成長率（CAGR）為6.2%。預測期內的成長要素包括：對個人化呼吸治療的需求不斷成長、整合數位健康功能的吸入器應用日益普及、家庭呼吸護理服務不斷擴展、對非侵入性給藥方式的日益重視以及吸入技術的持續創新。預測期內的主要趨勢包括：智慧互聯吸入器應用日益廣泛、對標靶肺部給藥的需求不斷成長、網狀霧化器和超音波霧化器的應用日益增多、藥物-器械組合產品的擴展以及對患者依從性的日益重視。

預計未來呼吸系統疾病盛行率的上升將推動肺部給藥裝置市場的成長。呼吸系統疾病是指影響肺部和氣道並損害正常呼吸功能的疾病。由於空氣污染加劇、吸煙率上升、都市化、氣候變遷和人口老化等因素，這些疾病的盛行率正在上升。肺部給藥裝置在呼吸系統疾病的治療中至關重要，因為它們能夠將藥物直接輸送到肺部，從而實現更快、更有效的治療。例如，根據美國疾病管制與預防中心 (CDC) 下屬的國家衛生統計中心的數據，截至 2025 年 5 月，2023 年確診的 18 歲及以上成年人慢性阻塞性肺病(COPD) 的年齡調整盛行率為 3.8%，與過去幾年的趨勢一致。因此，COPD 盛行率的上升正在推動肺部給藥裝置市場的成長。

肺部藥物輸送設備市場的主要企業正在開發創新產品，例如微型霧化器，以透過先進的功能更好地服務客戶。微型霧化器（SVN）是醫療設備，用於將液體藥物以霧化形式輸送給患有氣喘、慢性阻塞性肺病（COPD）和囊腫纖維化等呼吸系統疾病的患者。例如，2024年5月，美國醫療公司Medline Industries, LP推出了「Hudson RCI TurboMist」微型霧化器。這款突破性設備旨在僅需三分鐘即可完成藥物治療。這款創新霧化器每分鐘輸送的藥物量是標準霧化器的2.5倍，治療時間縮短了約70%。由於藥物輸送量的增加，治療時間顯著縮短，這不僅使醫護人員受益，最佳化了患者診療流程，也使患者受益，縮短了治療時間，改善了他們的就診體驗。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球肺部藥物輸送裝置市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 永續性、氣候技術和循環經濟
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 智慧型互聯吸入器設備的應用日益普及
    • 對標靶肺部給藥的需求日益成長
    • 擴大網狀霧化器和超音波霧化器的應用
    • 擴大藥品和醫療設備組合產品的範圍
    • 更加重視患者依從性

第5章 終端用戶產業市場分析

  • 醫院
  • 呼吸系統醫療設備
  • 居家醫療保健服務提供者
  • 零售藥房
  • 醫院藥房

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球肺部給藥裝置市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球肺部藥物輸送裝置市場規模、對比及成長率分析
  • 全球肺部藥物輸送裝置市場表現：規模與成長，2020-2025年
  • 全球肺部給藥裝置市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品類型
  • 乾粉吸入器、定量吸入器、霧化器
  • 透過使用
  • 氣喘、囊腫纖維化、慢性阻塞性肺病及其他適應症
  • 透過分銷管道
  • 零售藥局、醫院藥局、電子商務
  • 按類型細分：乾粉吸入器
  • 單劑量乾粉吸入器，多劑量乾粉吸入器
  • 按類型細分：定量吸入器
  • 氟氯化碳（CFC）定量吸入器、氫氟烴（HFA）定量吸入器
  • 按類型細分：霧化器
  • 噴射式霧化器、超音波霧化器、篩孔式噴霧器

第10章 區域與國家分析

  • 全球肺部給藥裝置市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球肺部給藥裝置市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 肺部藥物輸送裝置市場：競爭格局與市場佔有率（2024 年）
  • 肺部藥物輸送裝置市場：公司估值矩陣
  • 肺部藥物輸送裝置市場：公司概況
    • Medtronic plc
    • Air Liquide SA
    • Becton Dickinson And Company
    • Koninklijke Philips NV
    • Medline Industries Inc.

第37章：其他領先和創新企業

  • ResMed Inc., Dragerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici SpA, Teleflex Incorporated, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年肺部藥物輸送裝置市場：提供新機會的國家
  • 2030年肺部藥物輸送裝置市場：充滿新機會的細分市場
  • 2030年肺部藥物輸送裝置市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MPDDD01_G26Q1

Pulmonary drug delivery devices are inhalation devices designed to administer medications directly to the lungs. These devices enable targeted drug delivery for treating respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Additionally, pulmonary delivery allows for the systemic absorption of drugs such as insulin and pain medications.

The primary types of pulmonary drug delivery devices include dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers dispense a measured dose of medication in a fine, dry powder form that the patient inhales directly into their lungs. These devices are used for conditions such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and others. They are distributed through channels such as retail pharmacies, hospital pharmacies, and e-commerce.

Tariffs are impacting the pulmonary drug delivery devices market by increasing costs of imported plastics, electronic sensors, microvalves, drug canisters, and precision molding equipment used in inhalers and nebulizers. Pharmaceutical and medical device manufacturers in North America and Europe are most affected due to reliance on imported components, while Asia-Pacific faces cost pressure on large-scale device manufacturing. These tariffs are raising device prices and affecting market accessibility. However, they are also promoting regional manufacturing, local component sourcing, and innovation in cost-effective and reusable pulmonary delivery systems.

The pulmonary drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides pulmonary drug delivery devices market statistics, including pulmonary drug delivery devices industry global market size, regional shares, competitors with a pulmonary drug delivery devices market share, detailed pulmonary drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary drug delivery devices industry. This pulmonary drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pulmonary drug delivery devices market size has grown strongly in recent years. It will grow from $52.8 billion in 2025 to $56.49 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increasing prevalence of respiratory diseases, rising use of inhalation therapies, expansion of asthma and copd treatment programs, improvements in inhaler design technologies, growing awareness of pulmonary drug delivery.

The pulmonary drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $71.9 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing demand for personalized respiratory therapies, rising adoption of digital health integrated inhalers, expansion of home-based respiratory care, growing focus on non-invasive drug delivery, continued innovation in inhalation technologies. Major trends in the forecast period include increasing adoption of smart and connected inhaler devices, rising demand for targeted pulmonary drug delivery, growing use of mesh and ultrasonic nebulizers, expansion of combination drug-device products, enhanced focus on patient adherence.

The rising prevalence of respiratory disorders is expected to drive the growth of the pulmonary drug delivery devices market moving forward. Respiratory disorders are conditions that affect the lungs and airways, impairing normal respiration. The prevalence of these disorders is increasing due to factors such as higher levels of air pollution, rising smoking rates, urbanization, climate change, and an aging population. Pulmonary drug delivery devices are crucial in managing respiratory disorders, as they enable direct delivery of medications to the lungs for faster and more effective treatment. For instance, in May 2025, according to the US National Center for Health Statistics (via the CDC), the age-adjusted prevalence of diagnosed COPD among adults aged 18 and older in 2023 was 3.8 percent, reflecting an upward trend from previous years. Therefore, the increasing prevalence of COPD is driving the growth of the pulmonary drug delivery devices market.

Major companies in the pulmonary drug delivery devices market are developing innovative products, such as small-volume nebulizers, to better serve customers with advanced features. A small-volume nebulizer (SVN) is a medical device used to deliver liquid medication in the form of an aerosolized mist to patients with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. For instance, in May 2024, Medline Industries, LP, a US-based healthcare company, launched the Hudson RCI TurboMist small-volume nebulizer. This groundbreaking device is designed to deliver medication treatments quickly, in as little as three minutes. The innovative nebulizer can dispense 2.5 times more medication per minute compared to standard nebulizers, reducing treatment times by about 70%. This increase in medication delivery significantly reduces treatment times, benefiting healthcare providers by optimizing patient throughput and enhancing the patient experience by shortening the duration of therapy sessions.

In January 2025, Molex LLC, a US-based electronics and manufacturing company, acquired Vectura Group Ltd. for an undisclosed amount. Through this acquisition, Phillips Medisize, Molex's contract development and manufacturing arm (CDMO), strengthened its inhalation drug-delivery capabilities, enabling an expanded portfolio of combination products and device development. Vectura Group Ltd. is a UK-based pharmaceutical technology company specializing in pulmonary drug delivery devices.

Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson And Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Dragerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc.

North America was the largest region in the pulmonary drug delivery devices market in 2025. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pulmonary drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pulmonary drug delivery devices market consists of sales of jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pulmonary Drug Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pulmonary drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pulmonary drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulmonary drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
  • 2) By Application: Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Other Applications
  • 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; E-Commerce
  • Subsegments:
  • 1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs; Multi-Dose DPIs
  • 2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs; HFA-Based MDIs
  • 3) By Nebulizers: Jet Nebulizers; Ultrasonic Nebulizers; Mesh Nebulizers
  • Companies Mentioned: Medtronic plc; Air Liquide S.A.; Becton Dickinson And Company; Koninklijke Philips N.V.; Medline Industries Inc.; ResMed Inc.; Dragerwerk AG And Co. KGaA; Smiths Group plc; AptarGroup Inc.; Chiesi Farmaceutici S.p.A.; Teleflex Incorporated; Fisher And Paykel Healthcare Limited; Invacare Corporation; Vyaire Medical Inc.; Inogen Inc.; Drive DeVilbiss Healthcare Inc.; Hovione; Hamilton Medical AG; GaleMed Corporation; Allied Healthcare Products Inc.; Precision Medical Inc.; Salter Labs Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Pulmonary Drug Delivery Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Pulmonary Drug Delivery Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Pulmonary Drug Delivery Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Pulmonary Drug Delivery Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Sustainability, Climate Tech & Circular Economy
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Smart And Connected Inhaler Devices
    • 4.2.2 Rising Demand For Targeted Pulmonary Drug Delivery
    • 4.2.3 Growing Use Of Mesh And Ultrasonic Nebulizers
    • 4.2.4 Expansion Of Combination Drug-Device Products
    • 4.2.5 Enhanced Focus On Patient Adherence

5. Pulmonary Drug Delivery Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Pulmonology Clinics
  • 5.3 Home Healthcare Providers
  • 5.4 Retail Pharmacies
  • 5.5 Hospital Pharmacies

6. Pulmonary Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pulmonary Drug Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Pulmonary Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Pulmonary Drug Delivery Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Pulmonary Drug Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Pulmonary Drug Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pulmonary Drug Delivery Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pulmonary Drug Delivery Devices Market Segmentation

  • 9.1. Global Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
  • 9.2. Global Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications
  • 9.3. Global Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Retail Pharmacies, Hospital Pharmacies, E-Commerce
  • 9.4. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Dry Powder Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Dose DPIs, Multi-Dose DPIs
  • 9.5. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Metered Dose Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • CFC-Based MDIs, HFA-Based MDIs
  • 9.6. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers

10. Pulmonary Drug Delivery Devices Market Regional And Country Analysis

  • 10.1. Global Pulmonary Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Pulmonary Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pulmonary Drug Delivery Devices Market

  • 11.1. Asia-Pacific Pulmonary Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pulmonary Drug Delivery Devices Market

  • 12.1. China Pulmonary Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pulmonary Drug Delivery Devices Market

  • 13.1. India Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pulmonary Drug Delivery Devices Market

  • 14.1. Japan Pulmonary Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pulmonary Drug Delivery Devices Market

  • 15.1. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pulmonary Drug Delivery Devices Market

  • 16.1. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pulmonary Drug Delivery Devices Market

  • 17.1. South Korea Pulmonary Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pulmonary Drug Delivery Devices Market

  • 18.1. Taiwan Pulmonary Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pulmonary Drug Delivery Devices Market

  • 19.1. South East Asia Pulmonary Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pulmonary Drug Delivery Devices Market

  • 20.1. Western Europe Pulmonary Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pulmonary Drug Delivery Devices Market

  • 21.1. UK Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pulmonary Drug Delivery Devices Market

  • 22.1. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pulmonary Drug Delivery Devices Market

  • 23.1. France Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pulmonary Drug Delivery Devices Market

  • 24.1. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pulmonary Drug Delivery Devices Market

  • 25.1. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pulmonary Drug Delivery Devices Market

  • 26.1. Eastern Europe Pulmonary Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pulmonary Drug Delivery Devices Market

  • 27.1. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pulmonary Drug Delivery Devices Market

  • 28.1. North America Pulmonary Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pulmonary Drug Delivery Devices Market

  • 29.1. USA Pulmonary Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pulmonary Drug Delivery Devices Market

  • 30.1. Canada Pulmonary Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pulmonary Drug Delivery Devices Market

  • 31.1. South America Pulmonary Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pulmonary Drug Delivery Devices Market

  • 32.1. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pulmonary Drug Delivery Devices Market

  • 33.1. Middle East Pulmonary Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pulmonary Drug Delivery Devices Market

  • 34.1. Africa Pulmonary Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pulmonary Drug Delivery Devices Market Regulatory and Investment Landscape

36. Pulmonary Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 36.1. Pulmonary Drug Delivery Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Pulmonary Drug Delivery Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Pulmonary Drug Delivery Devices Market Company Profiles
    • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Air Liquide S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Pulmonary Drug Delivery Devices Market Other Major And Innovative Companies

  • ResMed Inc., Dragerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc.

38. Global Pulmonary Drug Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pulmonary Drug Delivery Devices Market

40. Pulmonary Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Pulmonary Drug Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Pulmonary Drug Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Pulmonary Drug Delivery Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer